It depends ... the treatment may be wanted, but unless it has a much higher cure rate than the current regimen, no insurer will offer it, and no single payer sy

It depends ... the treatment may be wanted, but unless it has a much higher cure rate than the current regimen, no insurer will offer it, and no single payer system will either. In the UK we have NICE (National Institute for Clinical Excellence) who make the decision over what drugs can be used on the NHS (and most private insurers use the same gradings), if it doesn't offer a clear benefit over the existing treatment in both effectiveness and then cost it won't be approved.